Personalized Insulin Management System with AI-Driven Predictive Analytics

A next-generation insulin management system that leverages machine learning, cloud-based platforms, wearable sensors, and blockchain technology to provide personalized, real-time insulin dosing and minimize the risk of hypoglycemia and hyperglycemia.

The original patent for insulin management addressed the need for accurate insulin dosing, but its manual calculations and limited data inputs led to suboptimal results. This new inventive concept tackles the limitations of the original patent by integrating advanced technologies to provide a more proactive, adaptive, and patient-centric approach to insulin management.

The system comprises a machine learning module that predicts blood glucose levels based on real-time sensor data, wearable devices for continuous glucose monitoring and insulin administration, a cloud-based platform integrating electronic health records and artificial intelligence, a telemedicine platform for remote insulin management, and a blockchain-based system for secure and transparent insulin management. These components work in tandem to optimize insulin administration, reduce healthcare costs, and improve patient outcomes.

The new claims introduce the use of machine learning, cloud-based platforms, wearable sensors, and blockchain technology to insulin management, which constitutes a significant departure from the manual calculations and limited data inputs of the original patent. The integration of these advanced technologies enables real-time, personalized insulin dosing and sets a new standard for insulin management.

Alternative embodiments may include the use of different machine learning algorithms, various wearable sensor designs, or alternative blockchain architectures. Additionally, the system could be adapted for use in different healthcare settings, such as clinics or hospitals, or integrated with other medical devices, such as continuous glucose monitors or insulin pumps.

The personalized insulin management system has vast commercial potential in the healthcare industry, particularly in the diabetes management market. The system's ability to reduce healthcare costs, improve patient outcomes, and provide real-time, personalized insulin dosing makes it an attractive solution for healthcare providers, payers, and patients alike.